Univest
Univest
  • Markets

Piramal Enterprises Analyst Review May 2026

  • May 21, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments
Piramal Enterprises Analyst Review

This Piramal Enterprises analyst review for May 2026 covers the key data investors need for PEL at its current price of Rs 1,100. Piramal Enterprises (NSE: PEL) is a diversified holding company with a market capitalisation of approximately Rs 30,000 crore, operating NBFC lending (Piramal Finance) and holding the Piramal Pharma stake. The analyst consensus target of Rs 1,350 implies meaningful upside, and this Piramal Enterprises analyst review examines technical levels, business performance, valuation, and key risks for PEL through FY27.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Piramal Enterprises Company Snapshot May 2026
  • Analyst Insight in This Piramal Enterprises Analyst Review
  • Technical Analysis in This Piramal Enterprises Analyst Review
  • Key Support and Resistance Levels
  • Business Segment Analysis
    • Piramal Finance NBFC (Wholesale to Retail Transition)
    • Home Loans and Digital Retail Lending
    • Piramal Pharma Stake (Listed Subsidiary)
  • Valuation in This Piramal Enterprises Analyst Review
  • Trade Outlook for Piramal Enterprises
  • Key Risks for Piramal Enterprises in FY27
  • Conclusion: Piramal Enterprises Analyst Review Verdict for 2026
  • Frequently Asked Questions: Piramal Enterprises Analyst Review 2026
    • What is the analyst target for Piramal Enterprises in 2026?
    • Is Piramal Enterprises a good investment at Rs 1,100?
    • What is Piramal Enterprises’s 52-week high and low?
    • What are the key risks for Piramal Enterprises?
    • Where can I track live data for Piramal Enterprises?

Piramal Enterprises Company Snapshot May 2026

Piramal Enterprises’ primary operating business is Piramal Finance (wholesale and retail NBFC), which is in a strategic shift toward retail lending (home loans, digital lending). The Piramal Pharma stake adds listed holding value. The table below summarises the key data referenced in this Piramal Enterprises analyst review.

Parameter Value
NSE Ticker PEL
Sector Diversified Financial and Pharma Holdings
CMP (May 2026) Rs 1,100
52 Week High Rs 1,480
52 Week Low Rs 900
Market Cap Rs 30,000 Crore
Trailing P/E NAx
Analyst Consensus Target Rs 1,350
Bull Case Target Rs 1,650
Bear Case Target Rs 900

Analyst Insight in This Piramal Enterprises Analyst Review

Associate Director Kunal Singla suggests watching Piramal Enterprises closely in May 2026. At Rs 1,100, Kunal Singla flags Diversified Financial and Pharma Holdings sector dynamics as the primary driver for PEL’s near-term price action. He notes support in the Rs 918 to Rs 1045 zone and flags any sustained close above Rs 1166 as a positive signal. Kunal Singla’s perspective on Piramal Enterprises adds professional analysis to this Piramal Enterprises analyst review and is not a buy recommendation.

Technical Analysis in This Piramal Enterprises Analyst Review

At Rs 1,100, PEL is trading within its 52-week band of Rs 900 to Rs 1,480. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.

Near-term support is identified in the Rs 918 to Rs 1045 band while resistance is seen in the Rs 1166 to Rs 1225 zone. A sustained move above Rs 1166 could open the path toward the analyst consensus target of Rs 1,350 as identified in this Piramal Enterprises analyst review.

Screen the best stocks on the Univest Screener.

Key Support and Resistance Levels

  • Support Zone: Rs 918 to Rs 1045 – investors tracking this Piramal Enterprises analyst review should watch for stabilisation or a bounce in this range as a potential accumulation signal for PEL.
  • Resistance Zone: Rs 1166 to Rs 1225 – a sustained close above Rs 1166 would be a positive breakout signal worth flagging in this Piramal Enterprises analyst review.
  • Medium-Term Target: The analyst consensus of Rs 1,350 represents the base-case upside scenario in this Piramal Enterprises analyst review.

Business Segment Analysis

Piramal Finance NBFC (Wholesale to Retail Transition)

This is the primary revenue and margin driver for Piramal Enterprises, directly supporting the earnings trajectory toward the consensus target of Rs 1,350.

Home Loans and Digital Retail Lending

This segment adds scale and diversification to Piramal Enterprises’s business model and is a meaningful EPS contributor through FY27 and FY28.

Piramal Pharma Stake (Listed Subsidiary)

This represents the medium-term growth frontier for Piramal Enterprises and a key re-rating catalyst for the stock over the next 12 to 24 months.

Valuation in This Piramal Enterprises Analyst Review

At Rs 1,100, Piramal Enterprises trades at a trailing P/E of NAx. This Piramal Enterprises analyst review presents three scenarios: a bull case of Rs 1,650 on strong earnings delivery, a base case of Rs 1,350 at analyst consensus, and a bear case of Rs 900 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this Piramal Enterprises analyst review.

Scenario Target Price Key Condition
Bull Case Rs 1,650 Strong earnings delivery and sector re-rating
Base Case (Consensus) Rs 1,350 Moderate growth, analyst consensus estimate
Bear Case Rs 900 Earnings miss or macro headwinds

Trade Outlook for Piramal Enterprises

Based on the technical and fundamental analysis in this Piramal Enterprises analyst review, investors might watch PEL near the support zone of Rs 918 to Rs 1045 for potential opportunities. A flag above Rs 1166 could suggest improving momentum toward Rs 1,350. This article uses watch-and-flag language only and does not constitute a trade recommendation.

Key Risks for Piramal Enterprises in FY27

A well-rounded Piramal Enterprises analyst review must assess downside risks. Key risks for Piramal Enterprises include a macro slowdown affecting Diversified Financial and Pharma Holdings sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in PEL.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Conclusion: Piramal Enterprises Analyst Review Verdict for 2026

This Piramal Enterprises analyst review concludes that at Rs 1,100, PEL offers a defined risk-reward with a consensus target of Rs 1,350. The 52-week range of Rs 900 to Rs 1,480 provides context on the current entry point. Use this Piramal Enterprises analyst review as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on PEL.

Frequently Asked Questions: Piramal Enterprises Analyst Review 2026

What is the analyst target for Piramal Enterprises in 2026?

The analyst consensus target is Rs 1,350, with a bull case of Rs 1,650 and a bear case of Rs 900. This Piramal Enterprises analyst review recommends monitoring Q1 FY27 earnings for confirmation.

Is Piramal Enterprises a good investment at Rs 1,100?

At Rs 1,100 with a P/E of NAx and a consensus target of Rs 1,350, this Piramal Enterprises analyst review is constructive for medium to long-term investors in the Diversified Financial and Pharma Holdings sector. Always consult a SEBI-registered advisor before investing.

What is Piramal Enterprises’s 52-week high and low?

The 52-week high is Rs 1,480 and the 52-week low is Rs 900. At Rs 1,100, PEL is positioned within this range as noted in this Piramal Enterprises analyst review.

What are the key risks for Piramal Enterprises?

Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the Diversified Financial and Pharma Holdings sector as assessed in this Piramal Enterprises analyst review.

Where can I track live data for Piramal Enterprises?

Track Piramal Enterprises’s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this Piramal Enterprises analyst review.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.



News Q4 Results
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply